Insiders · HOTH

HOTH insider transactions

Hoth Therapeutics Inc. (HOTH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for HOTH

• 13d
  SEC Form 4 filed by Director Linsley Wayne

  4 - Rocket One Inc. (0001711786) (Issuer)
• 13d
  SEC Form 4 filed by CEO and President Knie Robb

  4 - Rocket One Inc. (0001711786) (Issuer)
• 13d
  SEC Form 4 filed by Director Sarnoff David

  4 - Rocket One Inc. (0001711786) (Issuer)
• 13d
  SEC Form 4 filed by Director Camarra Christopher Michael

  4 - Rocket One Inc. (0001711786) (Issuer)
• 13d
  SEC Form 4 filed by Director Pavell Jeff

  4 - Rocket One Inc. (0001711786) (Issuer)
• 286d
  CEO and President Knie Robb was granted 800,000 shares and covered exercise/tax liability with 310,744 shares, increasing direct ownership by 842% to 547,387 units (SEC Form 4)

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 385d
  SEC Form 3 filed by new insider Camarra Christopher Michael

  3 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 511d
  SEC Form 4 filed by CEO and President Knie Robb

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 511d
  SEC Form 4 filed by Director Springer Graig

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 658d
  SEC Form 4 filed by Director Sarnoff David

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 658d
  SEC Form 4 filed by Director Pavell Jeff

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 658d
  SEC Form 4 filed by CEO and President Knie Robb

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 658d
  SEC Form 4 filed by Director Linsley Wayne

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 658d
  SEC Form 4 filed by Director Springer Graig

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 661d
  CEO and President Knie Robb bought $16,750 worth of shares (25,000 units at $0.67), increasing direct ownership by 75% to 58,131 units (SEC Form 4)

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 884d
  SEC Form 4 filed by Springer Graig

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 884d
  SEC Form 4 filed by Sarnoff David

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 884d
  SEC Form 4 filed by Pavell Jeff

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 884d
  SEC Form 4 filed by Linsley Wayne

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 884d
  SEC Form 4 filed by Knie Robb

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1058d
  SEC Form 4 filed by Knie Robb

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1058d
  SEC Form 4 filed by Sarnoff David

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1058d
  SEC Form 4 filed by Pavell Jeff

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1058d
  SEC Form 4 filed by Springer Graig

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1058d
  SEC Form 4 filed by Linsley Wayne

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1275d
  SEC Form 4: Pavell Jeff was granted 5,075 shares

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1275d
  SEC Form 3 filed by new insider Pavell Jeff

  3 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1360d
  SEC Form 4: Knie Robb bought $3,900 worth of shares (10,000 units at $0.39), increasing direct ownership by 1% to 828,259 units

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1360d
  SEC Form 4: Knie Robb bought $4,000 worth of shares (10,000 units at $0.40), increasing direct ownership by 1% to 818,259 units

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1545d
  SEC Form 4 filed by Knie Robb

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1545d
  SEC Form 4 filed by Sarnoff David

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1545d
  SEC Form 4 filed by Linsley Wayne

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1545d
  SEC Form 4 filed by Springer Graig

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1545d
  SEC Form 4 filed by Johns Stefanie

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1940d
  SEC Form 5: Inc. Pharma Aikido decreased ownership by 26% to 1,130,674 units

  5 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1940d
  SEC Form 4: Anthony Hayes sold $0 worth of Common Stock (0 units at $0.00)

  4/A - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1945d
  SEC Form 5: Robb Knie increased ownership by 0.00% to 808,259 units

  5 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by Graig Springer

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by David Sarnoff

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by Vadim Mats

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by Wayne Linsley

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by Robb Knie

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)
• 1955d
  SEC Form 4 filed by Stefanie Johns

  4 - Hoth Therapeutics, Inc. (0001711786) (Issuer)